Lawrence T. Weiss

Autre

Butterfly Network, Inc.Angiodynamics Inc

Insider activity · 24 months1 buy0 salesCumulative net flow

Nov 24 · 0 buys · 0 salesDec 24 · 0 buys · 0 salesJan 25 · 0 buys · 0 salesFeb 25 · 0 buys · 0 salesMar 25 · 0 buys · 0 salesApr 25 · 0 buys · 0 salesMay 25 · 0 buys · 0 salesJun 25 · 0 buys · 0 salesJul 25 · 0 buys · 0 salesAug 25 · 0 buys · 0 salesSept 25 · 0 buys · 0 salesOct 25 · 1 buy · 0 salesNov 25 · 0 buys · 0 salesDec 25 · 0 buys · 0 salesJan 26 · 0 buys · 0 salesFeb 26 · 0 buys · 0 salesMar 26 · 0 buys · 0 salesApr 26 · 0 buys · 0 salesMay 26 · 0 buys · 0 salesJun 26 · 0 buys · 0 salesJul 26 · 0 buys · 0 salesAug 26 · 0 buys · 0 salesSept 26 · 0 buys · 0 salesOct 26 · 0 buys · 0 sales

Total declarations

Companies

▲ Purchases (1 ops.)

€102k

▼ Sales (2 ops.)

€164k

Latest filing published 22 Jul 2026 for Angiodynamics INC.

Filing timeline

BuySale

Lawrence T. Weiss

Insider track record

Disclosed buys

Disclosed sells

T+90 hit rate

T+90 mean return

-11.9%

Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.

Signal history

Lawrence T. Weiss: trading record in brief

Lawrence T. Weiss has filed trades across 2 companies (mainly through SEC (Form 4)), most often in Angiodynamics Inc and Butterfly Network, Inc. Over a trading history stretching from 23 May 2022 to 16 July 2026, the count stands at 10 filings.

On the open market, the record shows 1 purchase worth €102k and 2 sales worth €164k. Sales outweigh purchases by €62k. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Outside the open market, there are 7 share grants.

The record was last updated on 22 July 2026 with a share grant in Angiodynamics Inc. The most recent open-market purchase was published on 22 October 2025, 367 days ago. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.